Navifus Corporation
Clinical trials sponsored by Navifus Corporation, explained in plain language.
-
Sound waves boost brain cancer drug in new trial
Disease control Recruiting nowThis study tests whether adding a focused ultrasound device (NaviFUS) to the standard drug Avastin helps people with recurrent glioblastoma (a type of aggressive brain cancer) live longer without their cancer growing. About 32 adults whose cancer returned after standard treatment…
Phase: PHASE3 • Sponsor: NaviFUS Corporation • Aim: Disease control
Last updated Jun 15, 2026 19:02 UTC
-
Sound waves may help brain cancer drug reach tumors
Disease control Recruiting nowThis early-stage study tests whether combining a standard brain cancer drug (bevacizumab) with focused ultrasound can safely treat recurrent glioblastoma, an aggressive brain tumor. About 10 adults whose cancer has returned after standard therapy will receive the combination. The…
Phase: PHASE1, PHASE2 • Sponsor: NaviFUS Corporation • Aim: Disease control
Last updated Jun 08, 2026 13:07 UTC
-
Sound waves aim to quiet seizures in Drug-Resistant epilepsy
Symptom relief Recruiting nowThis early study tests if low-intensity focused ultrasound can safely reduce seizures in people with temporal lobe epilepsy that doesn't respond to medication. Eight adults will receive the non-invasive treatment, and researchers will monitor side effects and changes in seizure f…
Phase: PHASE1, PHASE2 • Sponsor: NaviFUS Corporation • Aim: Symptom relief
Last updated Jun 15, 2026 18:55 UTC
-
Sound waves vs. seizures: new hope for Drug-Resistant epilepsy?
Symptom relief Recruiting nowThis study tests a device called NaviFUS™ that uses low-intensity focused ultrasound to calm overactive brain areas in people with drug-resistant epilepsy. About 16 adults will receive either the ultrasound treatment or a sham procedure to see if it safely reduces seizure frequen…
Phase: NA • Sponsor: NaviFUS Corporation • Aim: Symptom relief
Last updated Jun 15, 2026 18:54 UTC